Richard Umbdenstock, American Hospital Association president and CEO, said in a statement that while the organization is glad that a number of expiring hospital provisions were extended, “we need to ensure that all of the policies are maintained for the remainder of 2012.”
Rick Pollack, executive vice president at the AHA, said the group is especially displeased with a provision in the bill regarding outpatient therapy caps. According to a summary, the bill would extend an exceptions process for the caps through Dec. 31, 2012, with some changes. For example, all claims above the spending cap that do not include the proper billing modifier would be rejected, and all claims for high-cost beneficiaries would trigger a manual review to make sure that only medically necessary services are provided.
But for hospitals, the bigger issue with the changes to the outpatient therapy caps is a provision that requires spending caps in effect since 2006 to be extended to hospital outpatient department settings “to prevent a shift in the site of service to higher-cost settings once enforcement of the current exceptions process begins.” The summary noted that exempting services in the hospital outpatient department setting made sense when a hard therapy cap was in place, but is no longer appropriate, given the exceptions process.
Read the full story at: http://tinyurl.com/6pj895k
Source: Modern Healthcare
Hospitals were quick to assess a federal payroll tax bill that includes a short-term fix to Medicare's sustainable growth-rate formula, calling it another instance of cutting payments to providers rather than offering real reforms.
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More